These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14185778)

  • 21. [Modifications of the bacteriologic findings in tuberculotics subjected to treatment with rifamycin SV].
    NITTI V; VIRGILIO R; NINNI A
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():269-80. PubMed ID: 13938849
    [No Abstract]   [Full Text] [Related]  

  • 22. [THE USES OF RIFAMYCIN SV IN THE CLINICA TISIOLOGICA DI NAPOLI].
    RESCIGNO B
    Chemotherapia (Basel); 1963; 12():501-5. PubMed ID: 14185776
    [No Abstract]   [Full Text] [Related]  

  • 23. [Local application of rifamycin SV in caverns treated by endocavitary aspiration].
    SISTI F; VACCARO L
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():251-6. PubMed ID: 13977764
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE USE OF RIFAMYCIN SV REDUCES THE PERIOD OF INTRACAVITARY ASPIRATION].
    SISTI F
    Chemotherapia (Basel); 1963; 12():561-2. PubMed ID: 14185788
    [No Abstract]   [Full Text] [Related]  

  • 25. [THE USE OF RIFAMYCIN SV MAKES THE RESULTS OF INTRACAVITARY ASPIRATION MORE RAPID AND RELIABLE].
    VACCARO L
    Chemotherapia (Basel); 1963; 12():563-4. PubMed ID: 14185789
    [No Abstract]   [Full Text] [Related]  

  • 26. [RIFAMYCIN SV IN THE LOCAL THERAPY OF TUBERCULOUS CAVERNS IN TREATMENT WITH INTRACAVITARY ASPIRATION].
    BLASI A
    Chemotherapia (Basel); 1963; 12():542-8. PubMed ID: 14185781
    [No Abstract]   [Full Text] [Related]  

  • 27. [INTEGRATIVE THORACOPLASTY IN SUBJECTS TREATED WITH INTRACAVITARY ASPIRATION AND LOCAL RIFAMYCIN SV].
    MICILLO E
    Chemotherapia (Basel); 1963; 12():565-6. PubMed ID: 14185790
    [No Abstract]   [Full Text] [Related]  

  • 28. [BILIARY ELIMINATION OF RIFAMYCIN SV IN RELATION TO THE METHOD OF ADMINISTRATION].
    BECCARI E
    Chemotherapia (Basel); 1963; 12():388-90. PubMed ID: 14185762
    [No Abstract]   [Full Text] [Related]  

  • 29. [RIFOMYCIN SV IN LABORATORY TESTS].
    NINNI A
    Arch Tisiol Mal Appar Respir; 1963 Oct; 18():919-44. PubMed ID: 14097338
    [No Abstract]   [Full Text] [Related]  

  • 30. [CONSIDERATIONS ON 15 CASES OF ACUTE ATTACKS IN CHRONIC CHOLECYSTITIS, TREATED WITH RIFAMYCIN SV].
    ARIASVALLEJO E; DEMARCOSPEREZ VM
    Chemotherapia (Basel); 1963; 12():457-60. PubMed ID: 14191928
    [No Abstract]   [Full Text] [Related]  

  • 31. [RIFAMYCIN SV IN THE SUPPURATING AFFECTIONS OF THE LOCOMOTOR APPARATUS].
    BRENNER EA; GIANI O
    Sem Med; 1963 Jun; 122():1468-72. PubMed ID: 14069264
    [No Abstract]   [Full Text] [Related]  

  • 32. [1st experimental and clinical investigations on rifamycin SV in tuberculosis].
    LUCCHESI M
    Arch Tisiol Mal Appar Respir; 1963 Mar; 18():295-9. PubMed ID: 13931422
    [No Abstract]   [Full Text] [Related]  

  • 33. [KINETICS OF RIFAMYCIN SV, EXCRETION OF BROMSULPHALEIN AND BILIRUBINEMIA: EXPERIMENTS IN HUMANS].
    ACOCELLA G; BARONI GC; NICOLIS FB; TENCONI LT
    Chemotherapia (Basel); 1963; 12():401-8. PubMed ID: 14185764
    [No Abstract]   [Full Text] [Related]  

  • 34. [Parenteral rifomycin SV in treatment of advanced chronic pulmonary tuberculosis].
    Rey JC; Leston JM; Gonzalez Montaner LJ; Fernandez JM; Szemzo J; Martini MA
    G Ital Tuberc Mal Torace; 1965; 19(4):96-104. PubMed ID: 5846582
    [No Abstract]   [Full Text] [Related]  

  • 35. [RESEARCH ON THE BEHAVIOR OF TUBERCULIN ALLERGY DURING TREATMENT WITH RIFAMYCIN SV].
    NINNI A; MARCATILI S
    Arch Tisiol Mal Appar Respir; 1964 Mar; 19():191-205. PubMed ID: 14153331
    [No Abstract]   [Full Text] [Related]  

  • 36. [USE AND ACTION OF THE NEW ANTIBIOTIC RIFAMYCIN SV (RIFOCIN)].
    ANSCHEL R
    Wien Med Wochenschr; 1965 Mar; 115():197-202. PubMed ID: 14260791
    [No Abstract]   [Full Text] [Related]  

  • 37. [OBSERVATIONS ON TOLERANCE TO THE INTRASPINAL INTRODUCTION OF RIFAMYCIN SV].
    VERGA G; ZANETTI G
    Chemotherapia (Basel); 1963; 10():660-2. PubMed ID: 14184806
    [No Abstract]   [Full Text] [Related]  

  • 38. [LOCAL USE OF RIFOMYCIN-SV (RF-SV) IN PULMONARY TUBERCULOSIS. PRELIMINARY COMMUNICATION].
    CUCCHIANIACEVEDO R; LERNER S; FIORINO AR; IRURZUN A
    Arch Argent Tisiol Neumonol; 1963; 39():159-63. PubMed ID: 14126676
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience in the clinical use of rifamycin SV].
    Govorovich EA; Marshak AM; Iakovlev VP
    Antibiotiki; 1972 Nov; 17(11):1022-5. PubMed ID: 4664262
    [No Abstract]   [Full Text] [Related]  

  • 40. [Absorption and elimination of rifomycin SV intramuscular administration].
    ACOCELLA G; BARONI GC; MUSCHIO R
    G Mal Infett Parassit; 1962 Sep; 14():556-9. PubMed ID: 14041735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.